| Product ID |
Product Name |
CAS# |
Purity |
| Y3294852 |
2-Fluoro-3-iodo-6-methoxypyridine |
1227177-92-5 |
95% |
| Y3306824 |
10-Hydroxyaloin A |
134863-91-5 |
98% |
| Y3306529 |
1-(But-3-yn-1-yl)-4-chlorobenzene |
1456912-79-0 |
95% |
| Y3265293 |
RALA peptide |
1613231-49-4 |
99.69% |
| Y3290411 |
RNAIII-inhibiting peptide(TFA) |
2703745-76-8 |
99% |
| Y3297977 |
MC-GGFG-AM-(10Me-11F-Camptothecin) |
2873460-70-7 |
98% |
| Y3118072 |
EP2 receptor antagonist-2 |
615273-95-5 |
98% |
| Y3309176 |
9-Methoxyaristolactam I |
133462-30-3 |
98% |
| Y3266564 |
Lesogaberan hydrochloride |
2925644-17-1 |
98% |
| Y3269873 |
Tropicamide-d3 |
2673270-13-6 |
99.10% |
| Y3267516 |
EIF2a activator 2 |
1501618-04-7 |
99% |
| Y3287300 |
Ac-SVVVRT-NH2 |
1401804-69-0 |
98% |
| Y3307822 |
2-Chloro-1-fluoro-3-methoxy-4-nitrobenzene |
2088324-92-7 |
95% |
| Y3285911 |
DC-BPi-03 |
2758411-46-8 |
99% |
| Y3290350 |
Taragarestrant meglumine |
2446618-18-2 |
99% |
| Y3307993 |
Rubiayannone A |
517918-25-1 |
98% |
| Y3296112 |
KAT6-IN-1 |
2569008-99-5 |
99% |
| Y3118154 |
BPTF-IN-BZ1 |
2766623-38-3 |
98% |
| Y3290569 |
(S)-BAY 2965501 |
2732902-09-7 |
99% |
| Y3287555 |
Canocapavir |
2137847-19-7 |
98% |
| Y3307601 |
Regaloside K |
138772-00-6 |
90% |
| Y3289005 |
NBD-14270 |
2411819-82-2 |
98% |
| Y3268673 |
ISR-IN-2 |
1628478-12-5 |
98.21% |
| Y3271277 |
Selenomethylene blue |
85670-01-5 |
95% |
| Y3286395 |
Paroxetine-d4 hydrochloride |
2714485-95-5 |
99% |
| Y3294024 |
OARV-771 |
2683008-37-7 |
98% |
| Y3259773 |
Biotin-PEG4-dialkoxydiphenylsilane-picolyl azide |
2599839-59-3 |
95.02% |
| Y3286088 |
Glycocholic acid-d5 |
2170091-95-7 |
97% |
| Y3310114 |
Aristololactam IIIa |
97399-89-8 |
98% |
| Y3266742 |
CSNK1-IN-1 |
2468784-55-4 |
99% |
| Y3271246 |
MRK-898 |
461450-30-6 |
99.31% |
| Y3305728 |
(R)-CSN5i-3 |
2863607-74-1 |
97% |
| Y3262789 |
eIF4A3-IN-12 |
1402931-76-3 |
99% |
| Y3266586 |
(S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine |
2347517-69-3 |
99.06% |
| Y3263980 |
2-((tert-Butoxycarbonyl)amino)-4-(trifluoromethoxy)benzoic acid |
2306301-55-1 |
95% |
| Y3269773 |
PA3552-IN-1 |
1008121-12-7 |
98% |
| Y3293822 |
ZLN005-d4 |
2410443-42-2 |
99% |
| Y3289091 |
PD-1/PD-L1-IN-29 |
2665734-13-2 |
99% |
| Y3265191 |
(S,R,S)-AHPC-Me-C10-Br |
2836297-55-1 |
97% |
| Y3248370 |
Abemaciclib metabolite M18 hydrochloride |
2704316-82-3 |
98% |
| Y3311397 |
WDR5-IN-4 TFA |
2749300-35-2 |
99.87% |
| Y3261939 |
(E/Z)-GSK5182 |
2699724-40-6 |
99% |
| Y3306037 |
MS117 |
2702280-86-0 |
98.0% |
| Y3290549 |
RA375 |
2649154-57-2 |
99% |
| Y3295536 |
WF-47-JS03 |
2561413-77-0 |
99% |
| Y3306128 |
DBCO-(PEG)3-VC-PAB-MMAE |
2754384-60-4 |
95.67% |
| Y3293591 |
IRAK inhibitor 4 (trans) |
2070014-89-8 |
99% |
| Y3264168 |
MC3482 |
2922280-86-0 |
99% |
| Y3249180 |
HAEGTFTSDVSSYLE |
926018-57-7 |
98% |
| Y3317441 |
N-terminally acetylated Leu-enkephalin |
2703746-32-9 |
99.01% |
| Y3264169 |
S Tag Peptide |
7429-70-1 |
99% |
| Y3295426 |
Firsocostat (S enantiomer) |
2128714-16-7 |
98% |
| Y3287486 |
WKYMVM-NH2 TFA |
1435781-74-0 |
99% |
| Y3286131 |
Lotusine hydroxide |
3721-76-4 |
99% |
| Y3296042 |
LipidGreen 2 |
1382764-52-4 |
98% |
| Y3306629 |
(R)-eIF4A3-IN-2 |
2095484-82-3 |
95% |
| Y3248219 |
Fosnetupitant chloride monohydrochloride |
1643757-72-5 |
99.70% |
| Y3289999 |
NHS-SS-Ph |
2750799-12-1 |
95% |
| Y3289775 |
Hoechst 34580 tetrahydrochloride |
2310135-08-9 |
99% |
| Y3271895 |
MC-VA-PABC-MMAE |
1818864-51-5 |
99% |
| Y3296916 |
MT-VC-ZD02044 |
1800462-96-7 |
99% |
| Y3293662 |
DMA-135 hydrochloride |
2237925-62-9 |
98% |
| Y3262298 |
MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan |
2414254-41-2 |
95% |
| Y3248757 |
SARS-CoV-2-IN-13 |
56961-10-5 |
98.90% |
| Y3291870 |
CD38 inhibitor 2 |
2597933-78-1 |
98% |
| Y3268730 |
Boc-bipiperidine-ethynylbenzoic acid |
2308497-81-4 |
99.19% |
| Y3288252 |
PROTAC CBP/P300 Degrader-1 |
2484739-48-0 |
99% |
| Y3252686 |
NR2F6 modulator-1 |
904449-84-9 |
99.74% |
| Y3259899 |
APX2039 |
2342606-49-7 |
98.12% |
| Y3255239 |
ABR-238901 |
1638200-22-2 |
99.25% |
| Y3261409 |
MC-VA-PAB-Exatecan |
2680543-57-9 |
99% |
| Y3295677 |
CR-1-30-B |
1352914-53-4 |
99% |
| Y3268308 |
FT709 |
2413991-74-7 |
99% |
| Y3260426 |
PROTAC AR-V7 degrader-1 |
2767440-24-2 |
99.34% |
| Y3296763 |
AZD-CO-Ph-PEG4-Ph-CO-AZD |
2569143-72-0 |
96% |
| Y3297149 |
BSc3094 |
946857-84-7 |
98% |
| Y3286787 |
NBD-14189 |
2234273-72-2 |
99% |
| Y3104690 |
Pirepemat fumarate |
2251806-70-7 |
98.26% |
| Y3286736 |
Thalidomide-NH-CBP/p300 ligand 2 |
2484739-21-9 |
99% |
| Y3104662 |
Q134R |
2022949-46-6 |
99.55% |
| Y3104652 |
ERCC1-XPF-IN-2 |
1808986-37-9 |
98.78% |
| Y3295999 |
PROTAC ERRa Degrader-3 |
2306388-65-6 |
98% |
| Y3104644 |
N7-Methyl-guanosine-5'-triphosphate-5'-adenosine diammonium |
75252-10-7 |
98.82% |
| Y3292100 |
CD73-IN-5 |
2412019-99-7 |
98% |
| Y3289880 |
MPO-IN-3 |
1435469-45-6 |
99% |
| Y3294227 |
MC-Val-Cit-PAB-NH-C2-NH-Boc |
1616727-22-0 |
95% |
| Y3295394 |
(S,R,S)-AHPC-Boc-trans-3-aminocyclobutanol-Pip-CH2COOH |
2086301-47-3 |
99% |
| Y3104668 |
(S)-Baxdrostat |
1428652-16-7 |
98% |
| Y3286947 |
TBT1 |
52535-76-9 |
99% |
| Y3296183 |
SBI-993 |
2073059-82-0 |
98% |
| Y3291813 |
Cyhalothrin-d5 |
2411870-79-4 |
98% |
| Y3294657 |
Tyrosylleucine TFA |
66852-01-5 |
98% |
| Y3297076 |
GSK-2793660 |
1613458-78-8 |
99% |
| Y3104693 |
(S)-Enzaplatovir |
1323077-88-8 |
99% |
| Y3268468 |
(5)6-Carboxytetramethylrhodamine |
117557-83-2 |
98% |
| Y3310239 |
Itraconazole-d9 |
1309272-50-1 |
95% |
| Y3268469 |
RIG012 |
2642218-43-5 |
99.0% |
| Y3261584 |
Tanuxiciclib trihydrochloride |
1983984-11-7 |
98% |
| Y3252689 |
ELOVL6-IN-3 |
712346-06-0 |
98% |
| Y3270127 |
MC-VC-PAB-NH2 TFA |
1616727-21-9 |
99% |